Advaxis Inc (NASDAQ:ADXS)

23.34
Delayed Data
As of Apr 24
 -0.27 / -1.14%
Today’s Change
2.47
Today|||52-Week Range
24.48
+191.39%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$645.0M

Company Description

Advaxis, Inc. is a clinical-stage biotechnology company, which intends to develop immunotherapies for cancer and infectious diseases. The company's platform technology is designed to generate a comprehensive immune response by serving as its own adjuvant, directing antigen presentation, increasing tumor infiltrating killer T-cells, and decreasing Tregs/MDSCs in the tumor. Advaxis was founded on June 5, 1987 and is headquartered in Princeton, NJ.

Contact Information

Advaxis, Inc.
305 College Road East
Princeton New Jersey 08540
P:(609) 452-9813
Investor Relations:

Employees

Shareholders

Individual stakeholders23.66%
Other institutional22.30%
Mutual fund holders14.66%

Top Executives

Daniel J. O'ConnorPresident, Chief Executive Officer & Director
Gregory T. MayesCOO, Secretary, EVP & Head-Investor Relations
Sara BonsteinChief Financial Officer & Senior Vice President
Robert PetitChief Scientific Officer & Executive VP
Christy Lee FrenchVice President-Regulatory & Medical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account